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Materials and Methods 
Sample preparation 
Mammalian RNC harboring the signal sequence was prepared basically as 
described (12, 27). The DNA fragment having sequences for T7 promoter, Kozak, and 3 
× FLAG tag, followed by 
LDKLIRVGIILVLLIWGTVLLLKSIPHHSNTPDYQEPNSNYTNDGKLKVSFSVVRN
NTFHPKYHELH (hydrophobic signal sequence is underlined.) was cloned into 
EcoRI/PstI site of pUC57 plasmid (GenScript). After the digestion of the plasmid by PstI, 
mRNA was generated by in vitro transcription using T7 polymerase. The synthesized 
mRNA was purified by LiCl precipitation followed by ethanol precipitation. The purified 
mRNA was translated in the Flexi® Rabbit Reticulocyte Lysate System (Promega) at the 
mRNA concentration of 214 ng/µL for 25 min at 32°C. Then, 0.5 mL of ANTI-FLAG® 
M2 Affinity Gel (SIGMA-ALDRICH) equilibrated with buffer A (50 mM HEPES-KOH, 
pH 7.6, 100 mM KCl, 5 mM MgCl2) was added to 4.7 mL of the translation reaction 
product and gently mixed for 2 h at 4°C. Following the removal of the lysate, the gel was 
washed by 10 mL of buffer B (50 mM HEPES-KOH, pH 7.6, 500 mM KCl, 5 mM 
MgCl2) and then by 10 mL of buffer A. Then, RNCs were eluted by adding 5 mL of 
buffer A containing 0.1 mg/mL 3 × FLAG® Peptide (SIGMA-ALDRICH). The elution 
was collected with 0.5 mL/fraction. Fractions containing RNC were ultracentrifuged 
using a TLA55 rotor (Beckman Coulter) at 50,000 rpm at 4°C for 2 h, and the RNC pellet 
was resuspended into buffer C (50 mM HEPES-KOH, pH 7.6, 100 mM KOAc, 5 mM 
Mg(OAc)2). The final concentration of RNC was 1 µM and stored at -80 °C. 
Mammalian SR was prepared basically as described (26). The gene coding full-
length rabbit SRa and the cytosolic GTPase domain of rabbit SRb (residues from 60 to 
271) was cloned into pET20b and pET24a (Novagen), respectively. SRa and SRb were 
co-expressed in Escherichia coli BL21-SI strain (Invitrogen) having pRARE plasmid 
(Novagen). Produced SRa protein has an N-terminal His-tag for purification. Cells were 
cultured at 37°C in a 2.5 L medium containing 1.6% tryptone and 1% yeast extract. At 
OD600 = 0.5, NaCl and IPTG was added to the final concentration of 300 mM and 0.5 
mM, respectively. After culturing cells for 2 h at 37°C, they were collected by 
centrifugation at 5,000 g for 12 min. Cells were suspended into 50 mL of buffer D (20 
mM Tris-HCl, pH 7.6, 500 mM NaCl, 20 mM Imidazole, 5 mM MgCl2, 1 mM 2-
mercaptoethanol, 0.1 mM phenylmethylsulfonyl fluoride) and lysed by sonication. After 
pelleting cell debris by centrifugation at 48,000 g for 40 min, the supernatant fraction was 
applied onto 5 mL HisTrap HP column (GE Healthcare) equilibrated with buffer E (20 
mM Tris-HCl, pH 7.6, 500 mM NaCl, 20 mM Imidazole, 5 mM MgCl2, 1 mM 2-
mercaptoethanol). After washing the column by 75 mL of buffer E, SR was eluted by 30 
mL of buffer F (20 mM Tris-HCl, pH 7.6, 500 mM NaCl, 300 mM Imidazole, 5 mM 
MgCl2, 1 mM 2-mercaptoethanol). Elution was collected with 5 mL/fraction. Two 
fractions containing SR were mixed, and then 23 mL of buffer G (20 mM Tris-HCl, 
pH7.0, 1 mM DTT) was added. The sample was applied to 5 mL HiTrap SP HP column 
(GE Healthcare) equilibrated with buffer H (20 mM Tris-HCl, pH7.0, 150 mM NaCl, 1 
mM DTT). After washing the column by 15 mL of buffer H, SR was eluted by a 50 mL 
of NaCl linear gradient from 150 mM to 1 M. Fractions containing SR were mixed and 
concentrated with Amicon® Ultra-15 (Merck Millipore Ltd) to 5 mL. The concentrated 
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sample was applied to HiLoad 16/60 Superdex200 (GE Healthcare) equilibrated with 
buffer C. Fractions containing SR were mixed and concentrated with Amicon® Ultra-15 
(Merck Millipore Ltd). After pelleting aggregated proteins by centrifugation, the 
concentration of the supernatant fraction was 37.5 µM and stored at -80 °C.  
Sec61p was purified from the pig pancreas microsome essentially as previously 
described (39). 
 
Cryo-EM data collection 
RNC was mixed with purified dog SRP (tRNA probes), and incubated for 15 min 
at 25°C in the presence of 0.25% digitonin and 2 mM GMPPNP. SR was mixed with 
Sec61p, and incubated for 15 min at 25°C. Then, they were mixed and further incubated 
for 15 min at 25°C. We observed that the targeting complex assembled more efficiently 
in the presence of Sec61p, allowing us to collect a dataset with larger number of particles 
contributing to the final cryo-EM map. After that, the sample was incubated on ice. The 
final sample contained 200 nM RNC, 245 nM SRP, 1 µM SR, and 1 µM Sec61p. Cryo-
EM grids were prepared with the Vitrobot equilibrated at 4 °C and 100% relative 
humidity. 5 µL of the sample was applied onto the Quantifoil R2/2 holey carbon grid, 
which had been coated with thin carbon film and glow-discharged. The sample was 
incubated on the grid for 2 min. After blotting for 10 sec, grids were flash-frozen in liquid 
ethane. 
Data collection was performed on a Titan Krios electron microscope (FEI Company) at 
300 kV, using the EPU software (FEI Company) for automated data acquisition. Data 
were collected at a defocus of -1.2 to -3 µm at a magnification of 100,719x. Micrographs 
were recorded on Falcon II direct electron detector (FEI Company) as movie stacks. The 
exposure time for each movie stack was 1.4 sec, corresponding to an electron dose of ~40 
electrons/Å2 fractionated into 25 frames (55 msec/frame). After discarding the first and 
last frames, drift and gain corrections and dose-weighting were performed with 
MotionCor2 (40). 
 
Data processing and map calculation 
Contrast transfer function (CTF) was calculated from motion-corrected and non-
dose-weighted images using CTFFIND4 (41). After removing images having poor CTF 
quality, ribosome particles were semi-automatically picked from motion-corrected and 
dose-weighted images using Batchboxer implemented in EMAN (42). The following 
processing scheme of particle images by classification, refinement, and post-processing 
were performed using RELION2.0 (43, 44) (Fig. S1). Two datasets were collected and 
processed using an identical image-processing scheme. 493,114 particle images from 
dataset 1 and 282,676 from dataset 2 were extracted and binned four-fold (5.56 Å/pixel) 
and were processed by the two-dimensional (2D) classification and only 2D class 
averages of 80S ribosomes depicting high-resolution features were selected. From dataset 
1, 378,316 particle images were processed by the three-dimensional (3D) auto-refinement 
option against the map of the rabbit ribosome (EMD-2620) (45) low-pass filtered to 60 Å 
as the reference. The aligned particle images were processed by an initial 3D 
classification without image alignment focused on the SRP S domain. 50,823 particle 
images were selected yielding a class having strong signals of SRP RNA and the NG 
heterodimer at the SRP RNA distal site, and two-fold binned images (2.78 Å/pixel) were 
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processed by the 3D auto-refine with a mask on the 60S subunit, SRP and SR. To further 
improve the densities of SRP·SR, a 2nd 3D classification step focusing on the SRP RNA 
distal site only was performed, followed by a 3rd 3D classification step with the signal 
outside of the distal site subtracted from the images (46). 26,601 particle images were 
selected depicting the best class with the strongest density of SRP and SR and were 
combined with 19,207 particle images selected from the dataset 2 after following 
identical classification scheme as in dataset 1. Full-size particle images (1.39 Å/pixel) 
were processed by the 3D auto-refine, and generated the map of 3.8 Å resolution on 
average at a gold-standard FSC = 0.143 after post-processing. The overall average 
resolution of the final map is 3.7 Å from 45,800 particles after per-particle CTF 
correction using GCTF (47), 3D auto-refine and post-processing (Fig. S2A). The local 
resolution of the map was calculated using BLOCRES (48, 49) implemented in 
RELION2.0 (43) (Fig. S2C). To better visualize the density of SRP68/72 PBD attached 
to the SRP RNA, an additional classification was done by focusing on this region using 
particles after the 2nd classification (Fig. S5A). 26,515 and 21,295 particles were selected 
from dataset 1 and 2, respectively, depicting the strongest density of the SRP68/72 PBD. 
Full-size images of these particles were processed by the 3D auto-refine and the resulting 
overall average resolution of the map was 3.9 Å after post-processing. All maps were 
sharpened using auto-bfac option in RELION. 
 
Structure model building 
For the model building of SRP·SR·RNC complex, previously reported structure 
models were docked as a rigid body into the map using UCSF Chimera (50) and, if 
necessary, manually corrected using COOT (51). The models of RNC, hydrophobic 
signal sequence-bound SRP54 M domain, SRP Alu domain and P-site tRNA were built 
into the cryo-EM map based on the model of porcine RNC bound to SRP (PDB ID: 3JAJ) 
(27) and the crystal structure of  the SRP54 M domain  bound to SRP RNA (PDB ID: 
1MFQ) (52) and were manually adjusted. For the NG heterodimer of SRP54 and SRa, 
the human NG heterodimer model (PDB ID: 5L3Q) (18) were docked and corrected. For 
SRX·SRb, the heterodimer model (PDB ID: 2FH5) of human SRX and mouse SRb 
bound to GTP (30) was docked, and the helix a1x of SRX was modeled based on a 
homologous structure from yeast (PDB ID: 1NRJ) (34). For the SRP RNA in the S 
domain, human models were docked (PDB ID: 4P3E for 114-237, and PDB ID: 5M73 for 
106-113 and 238-249) and corrected (22, 31). In the SRP RNA docking process, models 
of SRP19, SRP68 RBD, and SRP72 RBD bound to it in the crystal structures were also 
fitted as a rigid body. For the hinge region of SRP RNA between S and Alu domains, the 
SRP RNA model of residues 87-105 and 250-262 (PDB ID: 4UE5) (53) was fitted and 
corrected. For the SRP68/72 PBD complex, the crystal structure of it (PDB ID: 5M72) 
(22) was tentatively docked into the map, considering the positions of the highly 
conserved basic residues (Arg90 and Arg121) of SRP72 PBD, through which it could 
attach to the SRP RNA (Fig. S5B and S5C). The sequences of SRP and SR component 
models were changed to those from dog and rabbit, respectively. For the model 
refinement, the cryo-EM map was converted to the map consisting of the sum of structure 
factors with blurred phase probabilities in a resolution dependent manner by the figure of 
merit (FOM) weighting as previously described (54). To remove clashes and regularize 
the geometry, the model of 60S·SRP·SR was subjected to one cycle of rigid body 
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refinement with PHENIX (55) (one rigid group for the 60S subunit, NG domains of 
SRP54 and SRa, SRX, SRb, and SRP RNA bound to SRP19, SRP68/72 and SRP54 M 
domain) and then followed by 11 cycles of individual B-factor and coordinate refinement 
against FOM weighted experimental electron microscopy phases and back-calculated 
structure factors using the phased maximum-likelihood (MLHL) target. To maintain good 
geometry, base pair, Ramachandran, and secondary structure restraints were imposed as 
previously described (54) due to limited resolution in certain areas. Model refinement and 
validation statistics of the 60S·SRP·SR and only of the SRP·SR regions are provided in 
Supplementary Table S1. 
 
Biochemical experiments using recombinant SRP and SR 
Human SRP54, SRP19, SRP9/14, SRabDTM (lacking nonessential luminal and 
transmembrane regions of SRb) and SRaDX (lacking SRX·SRb) were expressed in 
BL21(DE3) strains and purified as described (56-58). Human SRP68/72 was co-
expressed in yeast and purified as described in (59). Human SRP RNA (7SL) was in vitro 
transcribed and purified. Wild type and mutant SRP were assembled with modification of 
the procedures described by (59) and purified over a DEAE-sepharose column. 
Elongation arrest activity was measured by titrating wild type or mutant SRP into 
in vitro translation reactions of preprolactin (pPL) in wheat germ extract. Prolactin (PL), 
which does not contain a signal sequence, was translated in the same reaction to provide 
an internal standard. Translation was followed for 5 minutes, and the amount of 35S-
methionine labeled pPL relative to PL was analyzed by SDS-PAGE and autoradiography. 
Co-translational targeting and translocation of 35S-methionine labeled pPL into 
salt-washed, trypsinized rough ER microsome (TKRM) was measured as described (60, 
61). The efficiency of translocation for pPL was quantified as: 
 
The (8/7) term corrects for the different number of methionines in pPL versus signal 
sequence-cleaved. 
The reciprocally stimulated GTPase activities of SRP and SR variants were 
measured using a fixed, limiting amount of SRP, varying concentrations of SR, and 100 
µM GTP doped with g-32P-GTP. Reactions were monitored by thin layer chromatography 
as described (62). The SR concentration dependencies of observed GTPase rates were fit 
to the Michaelis-Menten equation to obtain values of kcat.   
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Fig. S1. 3D image classification scheme. 
3D classification procedure of ribosomal particles from data set 1. SRP·SR, ribosomal 
40S and 60S subunits are colored magenta, yellow, and light blue, respectively. 
Ribosomal particles from data set 2, classified in the same procedure, were combined 
with data set 1 before the final refinement step. See Materials and Methods for details. 
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Fig. S2. Fourier shell correlation curves, representative maps, and local resolution. 
(A) Curves of the Fourier shell correlation (FSC) values between two independently 
refined half maps for SRP·SR·RNC (black) and for SRP·SR calculated by masking out 
ribosomal density (green), and that between the map from full data and model (purple). 
The resolution of SRP·SR·RNC complex and SRP·SR is 3.7 Å and 6.6 Å, respectively 
based on the resolution criterion cutoff of the gold standard FSC value of 0.143 as 
implemented in RELION (44). The model correlates with the map to 3.8 Å resolution, 
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based on the resolution criterion cutoff of the FSC value between the map from full data 
and model of 0.5 (63). (B) Representative maps of the ribosomal protein eL31 helix 
(Arg41-Glu56) (left) and 28S rRNA region (right) shown in the gray mesh. For eL31, the 
helix is shown in the cartoon colored yellow, and side chains are in the stick model. 28S 
rRNA is shown in the stick model. The residue numbering is based on the previous model 
(PDB ID: 3JAJ) (27) (C) The map of SRP·SR·RNC complex low-pass filtered to 3.7 Å 
resolution is shown from two perpendicular directions. The map is colored to represent 
the local resolution based on the color bar on the right side. The local resolution of the 
map was calculated using BLOCRES (48, 49) implemented in RELION2.0 (43). (D) 
Representative maps of the SRP·SR·RNC complex low-pass filtered to 4.5 Å resolution 
for SRP54 NG domain helix (Lys114-Trp130) (left), SRP RNA (around the flipped-out 
base G232) (center), and the two GMPPNP molecules bound to NG heterodimer (right). 
The map of SRP54 is shown in gray mesh, and those of SRP RNA and GMPPNP are 
shown in two contour levels (gray and red mesh). The helix of SRP54 NG domain is 
shown in the cartoon colored light blue, and side chains are in the stick model. SRP RNA 
is shown in the stick model. Two GMPPNP molecules are shown in the stick model, and 
the NG heterodimer is shown and colored as in Fig. 1C. 
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Fig. S3. The map and structure model of SRP Alu domain and ribosomal tunnel 
exit.                                                                                                                                    
(A) The map of SRP·SR·RNC complex low-pass filtered to 3.7 Å resolution is shown 
and colored as in Fig. 1A from two perpendicular directions. The P-site tRNA is colored 
green. The Alu domain region of SRP highlighted by a square is shown in (B). (B) 
Structure model of SRP Alu domain bound to the ribosome fitted into the map from two 
perpendicular directions. The ribosome model is from the previous study (PDB ID: 3JAJ) 
(27). The map low-pass filtered to 6 Å resolution is colored gray. Models are shown and 
colored as in Fig. 1B. SRP9 and SRP14 are colored yellow and blue, respectively. (C) 
Same as (A) but from the different direction. The ribosomal tunnel exit region 
highlighted by a square is shown in (D). (D) Structure model of ribosomal tunnel exit 
region. The models are shown and colored as in Fig. 1B. The ribosomal protein uL23 is 
colored blue. The map is shown as in (B). The ribosomal tunnel exit is indicated by a 
circle. 
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Fig. S4. Models and maps of SRP and SR components in the S domain.  
(A-F) Models of SRP and SR components fitted into the map. Models are shown in 
cartoon and colored as in Fig. 1C. In (B) and (C), the map low-pass filtered to 4.5 Å 
resolution is shown. In the other panels, the map low-pass filtered to 6 Å resolution is 
shown. SRP68 RBD is shown in the higher threshold. 
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Fig. S5. SRP68/72 PBD attached to SRP RNA.                                                              
(A) The focused classification scheme of the data set 1 for the SRP68/72 PBD from the 
9.8% particles after the 2nd classification (Fig. S1). The shape of the mask used for the 
local 3D classification is represented as the dashed yellow line. Ribosomal particles from 
data set 2, classified in the same procedure, were combined with data set 1 before the 
final refinement step. The density of SRP68/72 PBD is pointed by the arrow. See 
Materials and Methods for details.  (B) The model of SRP68/72 PBD (PDB ID: 5M72) 
(22) was tentatively fitted into the map and is shown from two perpendicular directions. 
The map low-pass filtered to 8 Å resolution is colored gray. Models are colored as in Fig. 
1B. Arg90 and Arg121 of SRP72 are shown in spheres. (C) Part of the sequence 
alignment of SRP72 prepared as described (22). Arg90 and Arg121 are pointed by 
arrows. 
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Fig. S6. Structural comparison of SRP RNA and the signal sequence-bound SRP54 
M domain between SRP·RNC and SRP·SR·RNC complexes.                                    
(A) Structure model and map of SRP RNA in SRP·RNC complex (PDB ID: 3JAJ, EMD-
3037) (27). The SRP RNA, SRP54 M domain, and signal sequence is colored yellow, 
dark khaki, and green, respectively. The map low-pass filtered to 10 Å resolution is 
colored pink. (B) Structure model and map of SRP RNA in SRP·SR·RNC complex (this 
study). Models are colored as in Fig. 1B. The map low-pass filtered to 10 Å resolution is 
colored gray. The model of SRX·SRb is shown and colored as in Fig. 1B. (C) Structural 
comparison of SRP RNA between SRP·RNC and SRP·SR·RNC complexes. 
Superimposition of the two structures indicates a displacement of ~12 Å in the SRP RNA 
at the proximal site, shown as an arrow. 
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Fig. S7. Structural comparison of the mammalian SRP·SR·GMPPNP with bacterial 
SRP·SR·GDP·AlF4 on RNC.                                                                                          
SRP and SR components and GMPPNP or GDP·AlF4 molecules are shown as in Fig. 1C, 
except that SRP RNA is shown in the cartoon. (A) Mammalian SRP·SR·GMPPNP 
structure from two opposite directions (this study). (B) Bacterial SRP·SR·GDP·AlF4 
structure from two opposite directions (PDB ID: 5NCO) (29). The GM-linker connecting 
the NG and M domains of Ffh (bacterial SRP54) is colored yellow. 
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Fig. S8. Intermolecular interactions between the ribosome, NG heterodimer, SRP 
RNA, and SRP68 RBD at the SRP RNA distal site.                                                     
(A-D) The ribosome, SRP, and SR components are shown as in Fig. S4. GMPPNP 
molecules bound to the NG heterodimer are shown in the red spheres. The disordered 
loop between aN3 and aN4 of the SRP54 NG domain is shown as the dashed line. The 
ribosomal protein eL31 is colored yellow. SRP68/72 PBD is not shown for clarity. 
Secondary structure elements of proteins and the SRP68 RBD extended loop are labeled. 
The 28S rRNA region contacting SRP68 RBD extended loop is colored red. 
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Fig. S9. The conserved stacking interaction between the guanine base of SRP RNA 
and the phenylalanine residue of SR.                                                                             
(A) The stacking interaction between SRP RNA G232 and SRa Phe456 in mammalian 
SRP·SR·RNC complex (this study). The model is shown as in Fig. 1C but the SRP RNA 
G232 is shown in the stick model colored orange. The side chain of SRa Phe456 is also 
shown in the stick model. The map low-pass filtered to 4.5 Å resolution is shown as mesh 
at the two contour levels (gray and red ). (B) Stacking interaction between SRP RNA 
G83 and FtsY (bacterial SRa) Phe332 in bacterial SRP·SR·RNC complex shown as in 
(A) (PDB ID: 5NCO) (29). G83 of SRP RNA is colored orange. 
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Fig. S10. Structural comparison of SRb in mammalian SRP·SR·RNC complex with 
Ras in complex with GAP-334.                                                                                       
(A) Surface and cartoon representation of SRb bound to SRX and SRa NG domain at the 
SRP RNA distal site (top) and the close-up view of the GTP binding site of SRb (bottom)  
(this study). The model is shown and colored as in Fig. 1C and the GTP molecule is 
shown in the stick model. (B) Surface and cartoon representation of Ras bound to GAP-
334 (top) and the close-up view of the GTP binding site of Ras (bottom) (PDB ID: 
1WQ1) (35). Models of Ras and GAP-334 are colored wheat and red, respectively. The 
GTPase catalytic finger loop of GAP-334 is colored pink, and GDP and AlF3 molecules 
are shown in the stick model. 
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Fig. S11. Structural comparison of SRP RNA-bound SRP72 RBD in the isolated 
form and SRP·SR·RNC complex.                                                                                                    
(A) Structure model of SRP72 RBD bound to SRP RNA (PDB ID: 5M73) (22). SRP 
RNA and SRP72 RBD are shown in the cartoon colored orange and cyan, respectively. 
(B) Structure model and map of SRP72 RBD in SRP·SR·RNC complex (this study). 
Models are shown and colored as in Fig. 1B. The map low-pass filtered to 6 Å resolution 
is colored gray. 
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Fig. S12. Design of SRP variants.                                                                                       
(A) Sequence alignment of SRP72 C-terminal region (550-615, human numbering) 
prepared as in Fig. S5C (top) and the schematic diagram of designed human SRP72 (h72) 
variants (bottom). Note that this sequence alignment does not cover the whole C-terminal 
region of SRP72 (h72 has 671 residues.). (B) Secondary structure of human SRP RNA 
(7SL) (64). The 5f-loop is indicated by the red square, and A231 and G232 are pointed by 
arrows. 
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Fig. S13. Translation arrest and membrane targeting efficiencies of SRP variants.                               
(A) Translation arrest activities of wildtype and mutant SRPs were measured in wheat 
germ lysate as described in the Materials and Methods. The SRP concentration 
dependences of translational suppression of preprolactin (pPL) also provides a measure 
for the binding of SRP to RNCs bearing the pPL nascent chain. Data were reported as 
mean ±S.D., with n = 2. (B) Translocation efficiencies of pPL by human SRPs bearing 
indicated SRP72 mutations and/or SRP RNA mutations. All measurements contained 6 
nM of respective SRPs, SRabDTM, and 0.2 eq/µL salt-washed/trypsinized rough ER 
microsomes (TKRM). Translocation efficiencies were normalized to that of wildtype 
SRP. Data were reported as mean ±S.D., with n = 2-4.   
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Fig. S14. Reciprocally stimulated GTPase reactions of SRP with SR.                       
The GTPase activity was measured as described in the Materials and Methods. All 
reactions contained 200 nM wild type or mutant SRP fused to the signal sequence, 
indicated concentrations of SRabDTM, 250 nM 80S ribosome, and 100 µM GTP doped 
with g-32P-GTP. The lines are fits of the data to the Michaelis-Menten equation, which 
gave the values of kcat reported in Fig. 3C and 3D.  Data were reported as mean ±S.D., 
with n = 3-6. 
 
 
 
 
 
 
 
 
 
 
21 
 
Table S1. Data collection, structure model refinement, and validation statistics 
Data Collection   SRP·SR·60S (SRP·SR) 
Number of particles    45,800 
Voltage (kV)     300 
Defocus range (µm)    1.2-3.0 
Pixel size (Å)     1.39 
Electron dose (e-/Å2)    40 
Structure model refinement 
Resolution (Å)    3.7 (6.6) 
Map sharpening B-factor (Å2)  -204 
Average B-factor (Å2)   82.9 
r.m.s. deviations 
Bond length (Å)   0.006 
Bond angles (˚)   1.050 
Validation statistics 
Molprobity Score    3.2 (2.7) 
Clashscore, all atoms    15.8 (15.3) 
Protein 
Favored rotamers (%)    68.5 (85.3) 
Ramachandran plot 
Favored (%)    88.6 (95.0) 
Allowed (%)    99.4 (99.8) 
Outliers (%)    0.6 (0.2) 
RNA 
Correct sugar puckers (%)   95.4 (95.7) 
Good backbone conformations (%)  67.1 (72.7) 
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